Santa Farma's GEBKİM Facility Passes Peruvian Health Authority Inspection

Santa Farma, a longstanding pharmaceutical manufacturer in Turkey, has successfully passed a Good Manufacturing Practice (GMP) inspection of its production facility in Kocaeli-GEBKİM conducted by Peru's health authority (Dirección General de Medicamentos, Insumos y Drogas – DIGEMID). With this result, Santa Farma has earned the right to obtain an international GMP certificate valid through November 2030.

In the comprehensive inspection conducted between 17-21 November 2025, strong performance was demonstrated across quality management systems including production infrastructure, cleaning validation, deviation and documentation management, training processes, computerized systems and risk management.

Santa Farma Chief Executive Officer Sami Kiresepi stated in his assessment that they view quality as a fundamental element of the company's culture, emphasizing that this successful inspection outcome once again proves manufacturing competence and compliance with global standards. Furthermore, this achievement is being assessed as a strategic step that will strengthen the company's licensing and market access processes in the region.

Santa Farma, operating in the pharmaceutical sector for over 80 years, continues to pursue its vision of bringing local needs and international quality standards together in global markets.